Form 4: Medtronic President Receives Stock Grant
Insider Transaction (Form 4)
Kweli Thompson, EVP & President, Neuroscience of Medtronic plc, reported multiple transactions in common stock on July 31, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,739 Ordinary Shares at $85.39 ($148,493) on July 31, 2026; holds 28,467 after (Direct).
- Grant/award: acquired 6,923 Ordinary Shares on August 3, 2026; holds 35,390 after (Direct).
- Grant/award: acquired 17,306 Performance Share Units on August 3, 2026; holds 17,306 after (Direct).
- Grant/award: acquired 49,167 Stock Option (Right to Buy) on August 3, 2026; holds 49,167 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kweli Thompson — Officer (EVP & President, Neuroscience)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Tax/exercise-price withholding | Ordinary Shares | 1,739 | $85 | $148.5K | 28,467 |
| 2026-08-03 | Grant/award | Ordinary Shares | 6,923 | — | — | 35,390 |
| 2026-08-03 | Grant/award | Performance Share Units | 17,306 | — | — | 17,306 |
| 2026-08-03 | Grant/award | Stock Option (Right to Buy) | 49,167 | — | — | 49,167 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Tax/exercise-price withholding (1,739 shares) |
| 2026-08-03 | Grant/award (6,923 shares) |
| 2026-08-03 | Grant/award (17,306 shares) |
| 2026-08-03 | Grant/award (49,167 shares) |
Keywords
insider transaction, Form 4, MDT, Medtronic plc, neutral, Kweli Thompson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.